EVENT 27 / May / 2021

DIGITALISATION OF PHARMA 4.0 OPERATIONS

Madrid Marriott Auditorium

On 27/5/2021 in Madrid, Oytec held an event especially dedicated to end customers in the Pharmaceutical, Biotechnology and Cosmetics sector to showcase the latest technological advances.

A number of presentations were given, explaining the different trends in the management of plant operations, with a focus on the implementation of electronic batch records and their impact on company structure; from the impact on people to the technical and regulatory implementation required to carry out the project.

We were fortunate to have the invaluable collaboration of several speakers, who showed the way forward so that projects of this kind can be implemented with the greatest guarantees of return on investment.

Alicia Tébar from QBD showed us how strict regulation in the pharma sector has been one of the obstacles to introducing technological change in pharmaceutical plants.

Quality by Design moves towards incorporating the scientific knowledge needed to model, automate and ultimately digitalise the manufacturing process. The aim is to keep meeting high quality standards while clearly increasing efficiency and productivity. Quality systems are evolving towards this reality in order to make regulation compatible with innovation.

A basic assumption in chemical and pharmaceutical manufacturing is that, if process parameters are strictly controlled, the results will be identical.

Johan Hultman from Sartorius/Umetrics showed us, however, that this assumption is wrong, owing to the high variability in raw material quality between batches, and also because process variables will vary slightly during manufacturing, causing variations in the process and in the yield of the final product.

Developing multivariate data analysis (MVDA) models to monitor the normal evolution of the batch manufacturing process makes it possible to identify high-yield batches, known as the “Golden Batch”, and to investigate why some batches perform below the optimum.

José Valiente from CCI showed us the consequences of a cybersecurity incident in the digitalisation of an automated process in the pharmaceutical sector.

This included supply-chain risks, which in some cases could mean that OT systems are compromised or even held to ransom.

Juan Pedro Gallardo from Oytec, told us how new technologies create new opportunities and new professional profiles.

We need to invest in talent and training, and in supporting people through the process of updating and adapting their positions and roles.

The challenge is not the technology; it is managing change in people.

Joan Valls from Oytec, explained how, in general, any additional requirement arising from regulatory compliance generates a cost that the product will have to bear.

If, on top of that, it penalises my production capacity, we are facing a dramatic situation: rising regulatory costs, reduced production capacity and an exponential increase in cost per unit produced.

It would therefore seem that we are facing two opposing elements: ensuring audit trail & compliance, and moving closer to Operational Excellence.

Jordi Codina from Oytec, carried out the execution of an eBR Electronic Batch Record, where we were able to see the full operational and functional management:

Materials Management, Equipment, Logbooks, Weighing operations, Review by Exception, among others.

PARTNERS

Logo-QBD-Pharmaceutical-Services
logo-cci-ciberseguridad-Industrial
Logo-Sartorius
Logo-Oytec

GALLERY

If you would like to receive the presentations given at the event, please fill in the following form and we will send them to your e-mail address.

Choose presentations

2 + 13 =